Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy

Cancer

Volumn 120, Issue 23, 2014, Pages 3676-3682

  Mullen, John T ^a   Hornicek, Francis J ^a   Harmon, David C ^a   Raskin, Kevin A ^a   Chen, Yen Lin ^a   Szymonifka, Jackie ^a   Yeap, Beow Y ^a   Choy, Edwin ^a   DeLaney, Thomas F ^a   Nielsen, G Petur ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Neoadjuvant therapy; Outcome; Pathologic necrosis; Prognosis; Soft tissue sarcoma

Indexed keywords

DACARBAZINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIMB; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MYXOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TRUNK; TUMOR NECROSIS; ADJUVANT THERAPY; CHEMORADIOTHERAPY; COHORT ANALYSIS; DISEASE FREE SURVIVAL; HISTIOCYTOMA, MALIGNANT FIBROUS; LIPOSARCOMA, MYXOID; MIDDLE AGED; NECROSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SARCOMA; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME;

CHEMORADIOTHERAPY; COHORT STUDIES; DISEASE-FREE SURVIVAL; EXTREMITIES; FEMALE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; NECROSIS; NEOADJUVANT THERAPY; NEOPLASM GRADING; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TORSO; TREATMENT OUTCOME;

EID: 84913615948     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28945     Document Type: Article

References (23)

1. Picci P, Rougraff BT, Bacci G, et al. Prognostic significance of histo-pathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol. 1993; 11:1763-1769.
2. Picci P, Sangiorgi L, Rougraff B.T., Neff JR, Casadei R, Campanacci M. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994; 12: 2699-2705.
3. Picci P, Bohling T, Bacci G., et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol. 1997; 15:1553-1559.
4. Zunino JH, Johnston JO. Prognostic value of histologic tumor necrosis assessment in osteogenic sarcoma of bone. Am J Orthop (Belle Mead NJ). 2000; 29:369-372.
5. Bacci G, Mercuri M, Longhi A., et al. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with nonmetastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer. 2005; 41:2079-2085.
6. Lewis IJ, Nooij MA, Whelan J, et al.; MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst. 2007; 99:112-128.
7. Zalupski MM, Rankin C, Ryan J.R., et al. Adjuvant therapy of osteo-sarcoma-a Phase II trial: Southwest Oncology Group study 9139. Cancer. 2004; 100:818-825.
8. Pezzi CM, Pollock RE, Evans H.L., et al. Preoperative chemotherapy for soft tissue sarcomas of the extremities. Ann Surg. 1990; 211:476-481.
9. Eilber FC, Rosen G, Eckardt J., et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 2001; 19:3203-3209.
10. Henshaw RM, Priebat DA, Perry D.J., et al. Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol. 2001; 8:484-495.
11. Menendez LR, Ahlmann ER, Savage K, Cluck M., Fedenko AN. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma. Clin Orthop Relat Res. 2007; 455:219-224.
12. Lucas DR, Kshirsagar MP, Biermann J.S., et al. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation. Oncologist. 2008; 13:451-458.
13. MacDermed DM, Miller LL, Peabody T.D., et al. Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010; 76:1147-1153.
14. DeLaney TF, Spiro IJ, Suit H.D., et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003; 56:1117-1127.
15. Choong PF, Nizam I, Ngan S.Y., et al. Thallium-201 scintigraphy-a predictor of tumour necrosis in soft tissue sarcoma following preop-erative radiotherapy? Eur J Surg Oncol. 2003; 29:908-915.
16. Casper ES, Gaynor JJ, Harrison L.B., Panicek DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer. 1994; 73:1644-1651.
17. Jimenez RE, Zalupski MM, Frank J.J., Du W., Ryan JR, Lucas DR. Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy. Cancer. 1999; 86:976-981.
18. Schmidt RA, Conrad EU 3rd, Collins C, et al. Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer. 1993; 72:2593-2601.
19. Therasse P, Arbuck SG, Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000; 92:205-216.
20. Look Hong NJ, Hornicek FJ, Harmon D.C., et al. Neoadjuvant che-moradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Eur J Cancer. 2013; 49:875-883.
21. Choi H, Charnsangavej C, Faria S.C., et al. Correlation of computed tomography and positron emission tomography in patients with met-astatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007; 25:1753-1759.
22. Brisse H, Ollivier L, Edeline V., et al. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol. 2004; 34: 595-605.
23. Stacchiotti S, Verderio P, Messina A., et al. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012; 118; 5857-5866.